Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Clindamycin (300mg) Injection
Therapeutic Category
Antibacterials, Antibiotic, Dental, Dermatology, General and OTC medicines, Gynecology and Fertility, Pulmonary
Dosage Form
Injection
Packaging Type
White Tray Pack
Packaging
2 ML
Price
₹127/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Clinzadin 300 Injection is a sterile, parenteral formulation containing clindamycin, a lincosamide antibiotic, at a concentration of 300 mg per vial. This medication is primarily indicated for the treatment of serious infections caused by anaerobic bacteria, as well as certain infections caused by susceptible strains of Gram-positive bacteria. Clindamycin works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of the bacteria.
Clinzadin is particularly effective in treating skin and soft tissue infections, respiratory tract infections, and infections of the female genital tract. It may also be used in combination with other antibiotics to enhance therapeutic efficacy in polymicrobial infections. The injection is typically administered intravenously or intramuscularly, depending on the clinical situation and the severity of the infection.
Common side effects may include gastrointestinal disturbances, such as diarrhea, nausea, and abdominal pain, as well as potential allergic reactions.
Clinzadin 300 Injection is indicated for serious infections caused by anaerobic bacteria and certain Gram-positive bacteria.
Consult a healthcare professional before use, especially in cases of liver or kidney impairment.
Store at controlled room temperature, away from light. Do not freeze.
Composition : Clindamycin (600mg)
Composition : Colistimethate Sodium (1Million IU)
Composition : Colistimethate Sodium (2Million IU)
Composition : Clarithromycin (500mg) Injection
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (250mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftazidime (250mg)
Composition : Cefoperazone (500mg) + Sulbactam (500mg)
Composition : Cefepime (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Clindamycin 300mg Injection has strong demand in the hospital and critical care antibiotic segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Clindamycin 300mg Injection in serious bacterial infections, including intra-abdominal infections, respiratory infections, skin and soft tissue infections, and dental infections. It strengthens their injectable antibiotic portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Clindamycin 300mg Injection with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital demand, strong institutional sales potential, attractive margins, timely product availability, and professional marketing support when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Clindamycin 300mg Injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.